Cyclopharm Limited announced four management appointments. Dr. Mark Doverty as the Global Head of Regulatory Compliance and Clinical Research. Dr. Doverty joins the senior executive team with a Doctorate in Pharmacology and a distinguished career in healthcare and therapeutic goods regulation. Dr. Doverty was formerly the Head of the Office of Manufacturing Quality at the Australian Government's Therapeutic Goods Administration. Niamh McAree as Head of Quality and Regulatory. Ms McAree has extensive international experience in medical device and pharmaceutical manufacturing compliance with both Merck and Terumo. Most recently she consulted to Cyclopharm supporting the development of the company's Quality Management System, responding to the recent successful ISO and MDSAP audits. SallyAnn Cornelius as Head of Sales. Ms Cornelius is a specialist Molecular Imaging business development, sales and marketing professional with 20 years' experience working in Nuclear Medicine and Molecular Imaging. Sally Ann gained her experience with companies such as Global Medical Solutions and most recently Bayer Radiology, (formally Imaxeon), as Head of Molecular Imaging ANZ. Chris Quinn as Head of Service. Following a career in the Royal Australian Navy maintaining combat systems, Mr. Quinn first began working with medical devices in 2005 with Gammasonics. Chris then went on to create a service division at Global Medical Solutions Australia. In 2013, Chris moved to Bayer Radiology ANZ (formerly Imaxeon) to assist in building its Molecular Imaging division.